Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,643,666
+$507,391 QoQ
Shares Held
42,003
+37.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. TARS ranks #111 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,643,666 42,003
2026-03-31 $2,136,275 30,453
2025-12-31 $2,122,245 25,919
2025-09-30 $2,204,554 37,095
2025-06-30 $2,170,039 53,568
2025-03-31 $833,424 16,224
2024-12-31 $898,322 16,224
2024-09-30 $655,168 19,920
2024-06-30 $203,658 7,493
2024-03-31 $370,588 10,195